Comerica Bank’s Immunome IMNM Stock Holding History

Comerica Bank’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-82	Closed	-$1.2K	–	3711
2024 Q3	$1.2K	Buy	82 +48	+141%	+$682	﹤0.01%	3561
2024 Q2	$411	Hold	34	–	–	﹤0.01%	3630
2024 Q1	$839	Buy	+34	New	+$690	﹤0.01%	3636

Other funds holding IMNM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Comerica Bank's IMNM Position: Q4 2024 in Review

Comerica Bank sold out of Immunome (IMNM) in Q4 2024, closing a stake of 82 shares — an estimated $1.2K sold.

Comerica Bank first reported a position in IMNM in Q1 2024 and held it in 3 quarters. The position peaked at $1.2K in Q3 2024. 120 funds tracked by Wall St. Rank hold IMNM as of Q4 2024.

Comerica Bank reported no remaining Immunome position as of Q4 2024 after selling out during the quarter.
Comerica Bank sold 82 Immunome shares in Q4 2024, an estimated $1.2K.
Comerica Bank first reported a position in Immunome in Q1 2024 and held it in 3 quarters.
Comerica Bank's Immunome position peaked at $1.2K in Q3 2024.
120 funds tracked by Wall St. Rank held Immunome as of Q4 2024.

Based on Comerica Bank's 13F filing for Q4 2024, filed 14 Feb 2025.